Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) amplification, accounting for 10–15% of all breast cancers [1]. This evidence concerns the gene ERBB2 and breast cancer.